Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis

Sang Cheol Bae, Young Ho Lee

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: We evaluated the relationship between calprotectin levels and rheumatoid arthritis (RA), and the correlation between plasma/serum calprotectin and RA activity. Methods: We searched PUBMED, EMBASE, and Cochrane databases and performed meta-analyses comparing plasma/serum or synovial fluid calprotectin levels in RA patients and controls, and correlation coefficients between calprotectin levels and disease activity for 28 joints (DAS28) as well as C-reactive protein (CRP) in RA patients. Results: Sixteen studies including 849 RA patients and 266 controls were available for meta-analysis. Meta-analysis showed that calprotectin levels were significantly higher in the RA group than in the control group (SMD = 2.337, 95% CI = 1.544–3.130, p < 1.0 × 10–8). Stratification by rheumatoid factor (RF) status revealed significantly elevated calprotectin levels in the RF-positive RA group compared to that of the RF-negative RA group (SMD = 0.574, 95% CI = 0.345–0.804, p = 9.2 × 10–7). Meta-analysis of correlation coefficients identified a significant positive correlation between calprotectin levels and CRP or DAS28 (correlation coefficient for CRP = 0.566, 95% CI = 0.512–0.615, p < 1.0 × 10–8; correlation coefficient for DAS28 = 0.438, 95% CI = 0.269–0.518, p = 2.5 × 10–6). Calprotectin levels in synovial fluid were significantly higher in the RA group than in the control group (SMD = 2.891, 95% CI = 1.067–4.715, p = 0.002). Conclusions: Our meta-analysis demonstrates that circulating and synovial fluid calprotectin levels are high in patients with RA, and that circulating calprotectin levels positively correlate with RA activity.

Original languageEnglish
Pages (from-to)531-537
Number of pages7
JournalPostgraduate Medicine
Volume129
Issue number5
DOIs
Publication statusPublished - 2017 Jul 4

Fingerprint

Leukocyte L1 Antigen Complex
Meta-Analysis
Rheumatoid Arthritis
Rheumatoid Factor
Synovial Fluid
C-Reactive Protein
Control Groups
Serum

Keywords

  • activity
  • Calprotectin
  • rheumatoid arthritis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Calprotectin levels in rheumatoid arthritis and their correlation with disease activity : a meta-analysis. / Bae, Sang Cheol; Lee, Young Ho.

In: Postgraduate Medicine, Vol. 129, No. 5, 04.07.2017, p. 531-537.

Research output: Contribution to journalArticle

@article{5c567dd17c5f47f1b52cac2de4156946,
title = "Calprotectin levels in rheumatoid arthritis and their correlation with disease activity: a meta-analysis",
abstract = "Objective: We evaluated the relationship between calprotectin levels and rheumatoid arthritis (RA), and the correlation between plasma/serum calprotectin and RA activity. Methods: We searched PUBMED, EMBASE, and Cochrane databases and performed meta-analyses comparing plasma/serum or synovial fluid calprotectin levels in RA patients and controls, and correlation coefficients between calprotectin levels and disease activity for 28 joints (DAS28) as well as C-reactive protein (CRP) in RA patients. Results: Sixteen studies including 849 RA patients and 266 controls were available for meta-analysis. Meta-analysis showed that calprotectin levels were significantly higher in the RA group than in the control group (SMD = 2.337, 95{\%} CI = 1.544–3.130, p < 1.0 × 10–8). Stratification by rheumatoid factor (RF) status revealed significantly elevated calprotectin levels in the RF-positive RA group compared to that of the RF-negative RA group (SMD = 0.574, 95{\%} CI = 0.345–0.804, p = 9.2 × 10–7). Meta-analysis of correlation coefficients identified a significant positive correlation between calprotectin levels and CRP or DAS28 (correlation coefficient for CRP = 0.566, 95{\%} CI = 0.512–0.615, p < 1.0 × 10–8; correlation coefficient for DAS28 = 0.438, 95{\%} CI = 0.269–0.518, p = 2.5 × 10–6). Calprotectin levels in synovial fluid were significantly higher in the RA group than in the control group (SMD = 2.891, 95{\%} CI = 1.067–4.715, p = 0.002). Conclusions: Our meta-analysis demonstrates that circulating and synovial fluid calprotectin levels are high in patients with RA, and that circulating calprotectin levels positively correlate with RA activity.",
keywords = "activity, Calprotectin, rheumatoid arthritis",
author = "Bae, {Sang Cheol} and Lee, {Young Ho}",
year = "2017",
month = "7",
day = "4",
doi = "10.1080/00325481.2017.1319729",
language = "English",
volume = "129",
pages = "531--537",
journal = "Postgraduate Medicine",
issn = "0032-5481",
publisher = "Medquest Communications LLC",
number = "5",

}

TY - JOUR

T1 - Calprotectin levels in rheumatoid arthritis and their correlation with disease activity

T2 - a meta-analysis

AU - Bae, Sang Cheol

AU - Lee, Young Ho

PY - 2017/7/4

Y1 - 2017/7/4

N2 - Objective: We evaluated the relationship between calprotectin levels and rheumatoid arthritis (RA), and the correlation between plasma/serum calprotectin and RA activity. Methods: We searched PUBMED, EMBASE, and Cochrane databases and performed meta-analyses comparing plasma/serum or synovial fluid calprotectin levels in RA patients and controls, and correlation coefficients between calprotectin levels and disease activity for 28 joints (DAS28) as well as C-reactive protein (CRP) in RA patients. Results: Sixteen studies including 849 RA patients and 266 controls were available for meta-analysis. Meta-analysis showed that calprotectin levels were significantly higher in the RA group than in the control group (SMD = 2.337, 95% CI = 1.544–3.130, p < 1.0 × 10–8). Stratification by rheumatoid factor (RF) status revealed significantly elevated calprotectin levels in the RF-positive RA group compared to that of the RF-negative RA group (SMD = 0.574, 95% CI = 0.345–0.804, p = 9.2 × 10–7). Meta-analysis of correlation coefficients identified a significant positive correlation between calprotectin levels and CRP or DAS28 (correlation coefficient for CRP = 0.566, 95% CI = 0.512–0.615, p < 1.0 × 10–8; correlation coefficient for DAS28 = 0.438, 95% CI = 0.269–0.518, p = 2.5 × 10–6). Calprotectin levels in synovial fluid were significantly higher in the RA group than in the control group (SMD = 2.891, 95% CI = 1.067–4.715, p = 0.002). Conclusions: Our meta-analysis demonstrates that circulating and synovial fluid calprotectin levels are high in patients with RA, and that circulating calprotectin levels positively correlate with RA activity.

AB - Objective: We evaluated the relationship between calprotectin levels and rheumatoid arthritis (RA), and the correlation between plasma/serum calprotectin and RA activity. Methods: We searched PUBMED, EMBASE, and Cochrane databases and performed meta-analyses comparing plasma/serum or synovial fluid calprotectin levels in RA patients and controls, and correlation coefficients between calprotectin levels and disease activity for 28 joints (DAS28) as well as C-reactive protein (CRP) in RA patients. Results: Sixteen studies including 849 RA patients and 266 controls were available for meta-analysis. Meta-analysis showed that calprotectin levels were significantly higher in the RA group than in the control group (SMD = 2.337, 95% CI = 1.544–3.130, p < 1.0 × 10–8). Stratification by rheumatoid factor (RF) status revealed significantly elevated calprotectin levels in the RF-positive RA group compared to that of the RF-negative RA group (SMD = 0.574, 95% CI = 0.345–0.804, p = 9.2 × 10–7). Meta-analysis of correlation coefficients identified a significant positive correlation between calprotectin levels and CRP or DAS28 (correlation coefficient for CRP = 0.566, 95% CI = 0.512–0.615, p < 1.0 × 10–8; correlation coefficient for DAS28 = 0.438, 95% CI = 0.269–0.518, p = 2.5 × 10–6). Calprotectin levels in synovial fluid were significantly higher in the RA group than in the control group (SMD = 2.891, 95% CI = 1.067–4.715, p = 0.002). Conclusions: Our meta-analysis demonstrates that circulating and synovial fluid calprotectin levels are high in patients with RA, and that circulating calprotectin levels positively correlate with RA activity.

KW - activity

KW - Calprotectin

KW - rheumatoid arthritis

UR - http://www.scopus.com/inward/record.url?scp=85018827067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018827067&partnerID=8YFLogxK

U2 - 10.1080/00325481.2017.1319729

DO - 10.1080/00325481.2017.1319729

M3 - Article

C2 - 28425837

AN - SCOPUS:85018827067

VL - 129

SP - 531

EP - 537

JO - Postgraduate Medicine

JF - Postgraduate Medicine

SN - 0032-5481

IS - 5

ER -